Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5195 ARTÍCULOS , VIENDO DEL 3511 AL 3525

Advances in treatment of neurodegenerative diseases: Perspectives for combination of stem cells with neurotrophic factors

Wang J, Hu WW, Jiang Z, Feng MJ.

World J Stem Cells. 2020 May 26;12(5):323-338. doi: 10.4252/wjsc.v12.i5.323.

Ongoing Research on the Role of Gintonin in the Management of Neurodegenerative Disorders

Ikram M, Ullah R, Khan A, Kim MO.

Cells. 2020 Jun 15;9(6):1464. doi: 10.3390/cells9061464.

Targeting the endocannabinoid system: a predictive, preventive, and personalized medicine-directed approach to the management of brain pathologies

Reddy V, Grogan D, Ahluwalia M, Salles ÉL, Ahluwalia P, Khodadadi H, Alverson K, Nguyen A, Raju SP, Gaur P, Braun M, Vale FL, Costigliola V, Dhandapani K, Baban B, Vaibhav K.

EPMA J. 2020 Apr 15;11(2):217-250. doi: 10.1007/s13167-020-00203-4. eCollection 2020 Jun.

Rapidly Progressive Dementia and Temporal Lobe Atrophy in a Case of Nonketotic Hyperglycemic Hemichorea

Kammeyer RM, Orjuela KD.

Neurohospitalist. 2020 Jul;10(3):229-233. doi: 10.1177/1941874420902875. Epub 2020 Feb 10.

Evidence Linking Protein Misfolding to Quality Control in Progressive Neurodegenerative Diseases

Kabir MT, Uddin MS, Abdeen A, Ashraf GM, Perveen A, Hafeez A, Bin-Jumah MN, Abdel-Daim MM.

Curr Top Med Chem. 2020;20(23):2025-2043. doi: 10.2174/1568026620666200618114924.

How Do Post-Translational Modifications Influence the Pathomechanistic Landscape of Huntington's Disease? A Comprehensive Review

Lontay B, Kiss A, Virág L, Tar K.

Int J Mol Sci. 2020 Jun 16;21(12):4282. doi: 10.3390/ijms21124282.

Application of yeast to studying amyloid and prion diseases

Chernoff YO, Grizel AV, Rubel AA, Zelinsky AA, Chandramowlishwaran P, Chernova TA.

Adv Genet. 2020;105:293-380. doi: 10.1016/bs.adgen.2020.01.002. Epub 2020 May 4.

Huntington's Disease and Hypertension: Sorting Out Mixed Messages

Marras C, Mestre T, McDermott MP.

Mov Disord. 2020 Jun;35(6):915-917. doi: 10.1002/mds.28076.

Maximizing placebo response in neurological clinical practice

Mariani LL, Corvol JC.

Int Rev Neurobiol. 2020;153:71-101. doi: 10.1016/bs.irn.2020.04.003. Epub 2020 Jun 9.

Sydenham chorea in a12- year old Saudi girl

El-Shorbagy HH, Al Omari FK, Al Ghashmari HM, Al Zahrani SM, Ghoname MAK.

eNeurologicalSci. 2020 Jun 6;20:100246. doi: 10.1016/j.ensci.2020.100246. eCollection 2020 Sep.

Modelling neurodegenerative diseases with 3D brain organoids

Chang Y, Kim J, Park H, Choi H, Kim J.

Biol Rev Camb Philos Soc. 2020 Oct;95(5):1497-1509. doi: 10.1111/brv.12626. Epub 2020 Jun 22.

Validation of behavioral phenotypes in the BACHD rat model

Novati A, Manfré G, Flunkert S, Van der Harst JE, Homberg JR, Wronski R, Nguyen HP.

Behav Brain Res. 2020 Sep 1;393:112783. doi: 10.1016/j.bbr.2020.112783. Epub 2020 Jun 20.

Huntington's Disease-An Outlook on the Interplay of the HTT Protein, Microtubules and Actin Cytoskeletal Components

Taran AS, Shuvalova LD, Lagarkova MA, Alieva IB.

Cells. 2020 Jun 22;9(6):1514. doi: 10.3390/cells9061514.

Nanotechnology: A Promising Approach for Delivery of Neuroprotective Drugs

Naqvi S, Panghal A, Flora SJS.

Front Neurosci. 2020 Jun 9;14:494. doi: 10.3389/fnins.2020.00494. eCollection 2020.

MAP/ERK Signaling in Developing Cognitive and Emotional Function and Its Effect on Pathological and Neurodegenerative Processes

Albert-Gascó H, Ros-Bernal F, Castillo-Gómez E, Olucha-Bordonau FE.

Int J Mol Sci. 2020 Jun 23;21(12):4471. doi: 10.3390/ijms21124471.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias